Open Info Day: 4th Call for proposals

IMI held its Open Info Day on its 4th Call for proposals at the Husa President Park Hotel in Brussels, Belgium on Friday 17 June 2011. Over 200 participants attended, representing all types of organisations including SMEs, academic and industry research, patient organisations and government & policy decision makers.

The day included an overview of IMI’s funding and intellectual property (IP) rules, tips and testimonies from people involved in ongoing IMI projects, and presentations of the 4th Call topics by the Project Coordinators. In addition, there were plenty of networking opportunities during lunch and tea/coffee breaks. IMI staff were also on hand to answer questions relating to the 4th Call.

Agenda

More information on the 4th Call can be found here.

The videos of the Open Info Day plenary and workshop sessions are now available on the IMI YouTube Channel here

PRESENTATIONS

PLENARY SESSION:

Perspective of the European Commission on the 4th IMI Call
Ruxandra Draghia-Akli, Director Health, European Commission, Research & Innovation DG

EFPIA Perspectives
Richard Bergström, Director General

Introduction to IMI Procedures and Recent Project Achievements
Michel Goldman, IMI Executive Director

ROUND TABLE SESSION:
Panel Members

AFTERNOON PARALELL WORKSHOPS:

Workshop A: eTRIKS: European Translational Information and Knowledge Management Services
Introduction
Speakers' Presentation
Moderator: Ann Martin, Principal Scientific Manager, IMI
Speakers : Ian Dix, AstraZeneca & Sandor Szalma, J&J Pharmaceutical Research & Development LLC

Workshop B: Human induced Pluripotent Stem (hiPS) cells for drug discovery and safety assessment
Introduction
Speakers' Presentation
Moderator: Fatiha Sadallah, Principal Scientific Manager, IMI
Speaker: Laura Suter-Dick, Roche

Workshop C: Delivery and targeting mechanisms for biological macromolecules
Introduction
Speakers' Presentation
Moderator: Maria Teresa De Magistris, Principal Scientific Manager, IMI
Speakers :Ekkehard Leberer, Sanofi & Steve Hood, GSK
 
Workshop D: Sustainable Chemistry – delivering medicines for the 21st century
Introduction
Speakers' Presentation
Moderator: Hugh Laverty, Scientific Project Manager, IMI
Speakers: Philippe Mackiewicz, Sanofi Aventis & Joseph Adams, GlaxoSmithKline

Workshop E: Building up a European Medical Information Framework (EMIF) of patient-level data to support a wide range of medical research
This topic consists of 3 sub-topics:
i. Information Framework / Knowledge Management Service Layer
ii. Metabolic complications of obesity
iii. Protective and precipitating markers for the development of Alzheimer’s disease (AD) and other dementias
Introduction
Speakers' Presentation
Moderator: Ann Martin, Principal Scientific Manager, IMI
Speakers: Peter Egger, GlaxoSmithKline & Bart Vannieuwenhuyse, Johnson&Johnson

Workshop F: In vivo predictive biopharmaceutics tools for oral drug delivery
Introduction
Speakers' Presentation
Moderator: Hugh Laverty, Scientific Project Manager, IMI
Speakers: Bertil Abrahamsson, AstraZeneca & Mark McAllister, Pfizer
 
Workshop G: Understanding and optimising binding kinetics in drug discovery
Introduction
Speakers' Presentation
Moderator: Fatiha Sadallah, Principal Scientific Manager, IMI
Speakers: Mike J. Waring, AstraZeneca & Anke Mueller-Fahrnow, Bayer Healthcare